IRIDEX Corporation (IRIX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.3x

Market Cap

$12.26M

MomentumView details →

1D Return

−0.36%

YTD Return

−37.86%

RSI (14)

33.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.3x

Market Cap

$12.26M

RSI (14)

33.5

MomentumView details →

1D Return

−0.36%

YTD Return

−37.86%

SummaryUpdated Jul 1, 2026

IRIDEX Corporation (NASDAQ:IRIX) is a specialized ophthalmic medical technology company founded in 1989 and headquartered in Mountain View, California. The company went public in 1996 and has established itself as a provider of therapeutic laser systems and related devices for treating sight-threatening eye diseases. IRIDEX focuses primarily on two major areas of ophthalmology: glaucoma and retinal disorders, serving eye care professionals worldwide through both direct sales and international distribution networks.

Ask drillr about IRIDEX Corporation →

ProfitabilityView details →

Gross Margin

36.23%

Net Margin

−6.88%

EBITDA Margin

−3.31%

ROE (TTM)

−97.47%

ROA (TTM)

−13.01%

Asset Turnover

1.86x

GrowthView details →

Revenue YoY

+3.68%

EPS YoY

+38.23%

FCF YoY

+70.01%

Revenue CAGR 3Y

−2.58%

EPS CAGR 3Y

+51.85%

EBITDA YoY

+52.72%

EarningsView details →

EPS (Actual)

−$0.07

EPS Surprise

−600.00%

Beats (12Q)

6/12

Next Q EPS Est

−$0.04

Avg Surprise (4Q)

−114.88%

Rev Surprise

−7.51%

Capital & dividendView details →

Debt/Equity

1.10x

Current Ratio

1.82x

Quick Ratio

1.08x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

51.57M

Net Income (TTM)

−3.55M

Op. CF (TTM)

−1.73M

Next earningsNov 17, 2026 →

Latest newsMore news →

IRIDEX Corp received a notice from NASDAQ on 2026-08-27 stating it no longer meets the minimum bid price requirement under Rule 5550(a)(2), and has until 2027-02-23 to regain compliance.2d ago

Iridex Corporation reported its financial results for the second quarter ended July 4, 2026.17d ago

Similar companies

Adagio Medical Holdings, Inc.ADGM Sintx Technologies, Inc.SINT Biomerica, Inc.BMRA NeuroOne Medical Technologies CorporationNMTC Pulsenmore Ltd. Ordinary SharesPLSM HeartSciences Inc.HSCS Find similar companies →

Latest newsMore news →

IRIDEX Corp received a notice from NASDAQ on 2026-08-27 stating it no longer meets the minimum bid price requirement under Rule 5550(a)(2), and has until 2027-02-23 to regain compliance.2d ago Iridex Corporation reported its financial results for the second quarter ended July 4, 2026.17d ago